Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Word!
No sure if this an update on their site but they just posted it on the Meta Internet's :)
Have a good weekend .. most of you
https://aximbiotech.com/axim-eye/
Mepublican mantra.
"You guys may not be following the internet the way I do!"
It's a spec investment and to trade it, well you have to be nimble and quick and take advantage of bullshit posts that attract flies. The OTC is littered with the empty bank accounts of marks.
We are already over 1 million shares traded this morning .. looks 50/50 on who's sellin and buyin so far
Those two professions suffer from dry eye-noted-even. Waiting for pronouncements from the silent radar flyer on this one. Was it so smart someone bought out of the gate yesterday? Time will tell.
Right I mean if doctors and bodybuilders are buying the stock this thing could takeoff to dah moooooon
Could be the Doctor and the Bodybuilder.
A very smart investor buying right out of the gate this morning.
Who defrauded investors? The so called billionaires or others like DD SUMMIT. Remember it takes skill and some luck to be a successful trader.
My own opinion is that there was a coordinated effort to defraud Investors....I think.there needs to be a substantial amount of incarceration to attone for that. However, that is just my opinion.
That's interesting. It reads almost like some of John's videos from late 2020. Time is not what most people think it is. The past, present and future coexist on the hologram.
Not to bring up the past but there seems to be an interest again in immunity levels.
https://www.msn.com/en-us/health/medical/a-simple-blood-test-could-reveal-how-strong-your-covid-immunity-is/ar-AAYykbH?ocid=msedgdhp&pc=W012&cvid=d1b94c43fa454cdba900adb33ff13f19
Hoping this misadventure will be put behind him and he has learned from it. His family will survive intact which is great-a son needs his father and a wife her husband, and he will need them both. I wish him well on his future after this incident.
And now for something completely different.
He has a sentencing date in a few months, he won't be able to post after that.
No need to worry. John is "Staying Cool and Staying Awesome". Its good to see him smiling and happy again.
Did you ever receive a satisfactory response to the kit manufacturing now it became clear Immunopass was Immunofail and DED was to help wipe away those tears of dissapointment?
You should discuss that with your legal counsel.
Does it mean that AXIM is likely a scam because BLSQ was promoting the business prospects here?
Yes but that should not imply Axiom is a scam, that would be quite a leap. He was heavily involved with another company that was delisted but I doubt whether he had the same pull with insiders of Axiom.
so, John Drago, was Squirrel, the same person going to jail (likely), was moderating this board?!?!?!!?!
...sometimes wolves in sheeps clothing are difficult to identify...
The government writes in response to the United States Department of Probation’s May 17, 2022 Presentence Investigation Report (“PSR”) concerning the above captioned case. Paragraph 28 of the PSR incorrectly deducts one point from the defendant’s Total Offense Level based upon the defendant’s “timely acceptance of responsibility.” (See PSR at ¶ 28 (citing U.S.S.G. § 3E1.1(b)). As set forth in the parties’ Plea Agreement, however, the government will not be making a motion for an additional point deduction.
This is because the government expended significant effort in preparing for trial in this case, including litigating the admissibility of more than 250 exhibits in two complex pre-trial suppression hearings.
In addition, the PSR contains inaccurate information concerning the defendant’s military record. (See PSR at ¶62). To provide the Court with correct information concerning the defendant’s time in the military, the government will be filing an additional letter and documents obtained from the United States Army under seal."
Sentencing set for 10/21/2022 at 02:00 PM in Courtroom 940 before Judge Gary R. Brown. Ordered by Judge Gary R. Brown on 6/3/2022.
AXIM board content is certainly tainted
Yes and he was formerly known as The Lieutenant before switching his nic to Blind Squirrel.
Squirrel Boy = John Drago?????
is this the same Drago:
Owner of Long Island Commercial Check Cashing Companies Pleads Guilty to Financial Fraud
John Drago Structured Transactions to Assist Customers in Evading Taxes and Operated an Off-the-Books Payroll
Earlier today, in federal court in Central Islip, John Drago, the former owner/operator of several check cashing businesses on Long Island, pleaded guilty to illegally structuring financial transactions and payroll tax evasion. The proceeding took place before United States District Judge Gary R. Brown. When sentenced, Drago faces up to 10 years in prison, has agreed to forfeit approximately $253,000 and to pay restitution of approximately $593,000. As part of his plea, Drago is required to surrender his check cashing licenses, his federal money services business registrations and he is barred from applying for any such licenses or registrations in the future.
Jacquelyn M. Kasulis, Acting United States Attorney for the Eastern District of New York, and Thomas Fattorusso, Acting Special Agent-in-Charge, Internal Revenue Service Criminal Investigation, New York (IRS-CI), and Shirin Emami, Acting Superintendent, New York State Department of Financial Services (DFS), announced the guilty plea.
“Drago’s guilty plea makes clear that running a check cashing business is not a license to evade financial reports to cheat the IRS or a blank check for committing fraud,” stated Acting United States Attorney Kasulis. “This Office will prosecute and hold to account defendants like Drago who, under the guise of running a legitimate business, are actually engaging in egregious schemes to avoid paying taxes.”
$AXIM Continuing breakout pattern. Increasing technicals
double dead squirrel bounce - SCAMOLA
Yup. Out for now. Will return when I see another opp again.
A friend added over a million shares last week. I checked with him and he has no idea who is buying this week.
Agree. This Sapphire Biotech team has always been top notch in my opinion.
I will give John Huemoeller a lot of credit for assembling a very impressive DED Advisory Board.
The DED business is NOT a scam as JaneyH says. However there are still some regulatory hurdles the doctors offices have to clear before they can use these new tests.
It would be nice if the FDA grants a CLIA waver for these DED tests, but AXIMinvestors have waited on the FDA far too long. Help the eye doctors become CLIA compliant and let's move forward without the FDA.
My guess is maybe one of the doctors on the DED advisory board decided to buy 1 million shares. just a guess. This is not investment advice.
1,000,000 × $0.12 = $120,000.
$120,000 is not much money to move the share price.
There's your pop in the share price and volume :)
Just imagine what the stock price would be today if the neutralizing antibody test had been approved by the FDA. Nevertheless its as exciting as can be to be in at the birth of a new biotech with DED products in the deployment phase and a bunch of cancer related products on deck and the smart guys from Sapphire doing what they do creating new products. I'm forecasting an 8K on or before June 21 based on the 10Q.
There is no uncertainty!!
The 510K FDA approved DED tests require CLIA certified labs. Please read pages 41 and 42 of the last 10-Q.
AXIM setup a brand new website for selling these DED Eye tests. There is much information explaining how Eye Doctors offices can become CLIA certified.
There is no uncertainty!! Currently only CLIA approved sites can sell and administer these DED 510K FDA approved Dry Eye disease Tests.
https://aximeye.com/clia-application-process/
The market cap is $12 million. If we actually have sales this year of DED tests to ophthalmologists and optometrists and there is a real need for these tests then the valuation could be too low. Janey thinks this is a scam. I see it more as unfortunate the way the NAB test never got used by the public.
What sort of yearly revenues could we hope for from DED? It is a simple test to do in the clinic but there is some question on whether the FDA would require a certified laboratory to do the tests. This uncertainty needs to be cleared up.
I don't care what you call it. I'm going to make at least 20% on my shares.
The bounce is upon us. Please remember to take profits into strength.
$AXIM 10sma crosses 20sma after double .055 bottom. Increasing OBV. Increasing Momentum. RSI in 50’s. Watching closely
this stock is a swirling squirrel turd, if there is a bounce, it is a dead squirrel bounce
Who is this Johnny Drago character and how is he related to AXIM? Is he somehow affiliated with the company - via employment or services arrangement - or information on this board?
Followers
|
105
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
5296
|
Created
|
04/29/14
|
Type
|
Free
|
Moderators Blue Skys Squirrel Hunter |
Unlike currently available serological COVID-19 tests that detect an antibody response to the virus, AXIM’s rapid 10-minute test measures a specific subpopulation of antibodies to block binding of the virus to host cell receptors. While there are expensive, time consuming laboratory tests that measure neutralizing antibodies, NeuCovixTM differs in that it is a portable, low cost, rapid point-of-care test with results in 10 minutes.
“We are hopeful our test fills an important need in these uncertain times. While other tests merely show whether someone was infected with coronavirus, we took it a step further by creating a test that stratifies individuals into those who have neutralizing antibodies, which are essential in preventing reinfection, and those who don’t. The test can be deployed for point of care use in convalescent plasma transfusions to severely ill patients and for evaluating efficacy of upcoming vaccines in generating protective antibodies,” said Sergei Svarovsky, PhD, MBA, AXIM’s CSO and co-inventor of NeuCovixTM.
An immediate application of NeuCovixTM, a point-of-care test, is to measure levels of neutralizing antibodies in convalescent plasma so that plasma with the highest levels of neutralizing antibodies can be identified and administered to patients fighting COVID-19. Without this knowledge, many patients could be undertreated with non-neutralizing plasma and may not benefit from this treatment.
Another application of NeuCovixTM is to help ensure that vaccines elicit high levels of neutralizing antibodies. When a vaccine is available, manufacturers can employ the NeuCovixTM rapid, point-of-care test to evaluate protective immune responses in vaccine recipients.
AXIM® Biotech CEO John W. Huemoeller II commented, “Our goal was to make this test, accurate, fast and relatively inexpensive so it could serve as an ‘Immunity Passport port™’ for vaccine developers around the world as they begin larger Phase II and III clinical trials. We are optimistic that NeuCovixTM will be widely used, becoming the gold standard in assessing levels of immunity.”
Doug Lake, Ph.D. and co-inventor of NeuCovixTM commented, “Everybody who recovers from COVID-19 makes antibodies against the virus, but since all antibodies are not created equal, you really want to know if the antibodies you make neutralize the virus. People who recover want to make sure they are protected from re-infection and that they won’t infect others.”
AXIM also announced the filing of a pre-Emergency Use Authorization Application (EUA) and has already initiated dialogue with the FDA in order to finalize its EUA submission. The intellectual property relating to the novel serological test is the subject of Provisional Patent Application No. 63/023,646 “Convalescent Plasma Testing and Treatment” filed on May 12, 2020.
About AXIM® Biotechnologies
Founded in 2014, AXIM® Biotechnologies, Inc. (AXIM) is a vertically integrated oncology company developing rapid diagnostic tests for the early detection of cancer and proprietary small molecules drugs to treat cancer and block metastasis. The Company is also developing novel antibodies for therapeutic and diagnostic uses for oncological therapeutics. For more information, please visit www.AXIMBiotech.com.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |